Galcanezumab-Gnlm
Brand name: Emgality Pen
Rank #180 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$87.0M
Total Cost
101,221
Total Claims
$87.0M
Total Cost
3,254
Prescribers
$859
Cost per Claim
7,572
Beneficiaries
115,544
30-Day Fills
$27K
Avg Cost/Provider
31
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$87.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $87.0M total
🔎 Data Overview
Average cost of $11,484 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Galcanezumab-Gnlm
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Robert Pearlman | Neurology | Birmingham, AL | 538 | $402K |
| 2 | Lance Kim | Neurology | Ocala, FL | 444 | $372K |
| 3 | Naga Lakshmana Nidadavolu | Neurology | Saint Cloud, FL | 416 | $366K |
| 4 | Laura Hediger | Nurse Practitioner | Springfield, MO | 232 | $285K |
| 5 | Jennifer Parrish | Nurse Practitioner | Dothan, AL | 374 | $283K |
| 6 | Fernando Gonzales-Portillo | Internal Medicine | Orlando, FL | 318 | $230K |
| 7 | Franchesca Fiorito-Torres | Neurology | Guaynabo, PR | 324 | $227K |
| 8 | Leah Thronaum | Neurology | Saint Cloud, MN | 180 | $209K |
| 9 | Maria Carmen Wilson | Neurology | Covington, LA | 251 | $196K |
| 10 | David Walker | Neurology | Sacramento, CA | 219 | $196K |
| 11 | Winthrop Risk | Neurology | Cedar Rapids, IA | 213 | $194K |
| 12 | Charles Schultz | Neurology | Ann Arbor, MI | 218 | $187K |
| 13 | Kate Williams | Nurse Practitioner | Worcester, MA | 222 | $182K |
| 14 | Mohammed Pathan | Neurology | Columbus, GA | 158 | $179K |
| 15 | Haley Mertz | Physician Assistant | Dalton, GA | 229 | $173K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 177 | Lamotrigine (Lamotrigine) | $89.0M | 1,603,798 |
| 178 | Insulin Aspart Prot/Insuln Asp (Novolog Mix 70-30 Flexpen) | $88.8M | 79,814 |
| 179 | Teduglutide (Gattex) | $88.4M | 1,758 |
| 180 | Galcanezumab-Gnlm (Emgality Pen) | $87.0M | 101,221 |
| 181 | Imatinib Mesylate (Imatinib Mesylate) | $85.0M | 40,908 |
| 182 | Clopidogrel Bisulfate (Clopidogrel) | $84.7M | 5,428,304 |
| 183 | Famotidine (Famotidine) | $84.3M | 5,257,365 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology